Epithelial-mesenchymal transition in prostatic disease

Area of Science:

• Urology
• Cell Biology
• Oncology

Background:

• Normal prostate epithelium undergoes epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition.
• These processes involve phenotypic changes crucial for understanding prostate gland development and aging.

Purpose of the Study:

• To review the phenotypic changes associated with EMT and its reverse process in the context of prostate growth disorders.
• To explore the role of transcriptional programming in these transitions within benign prostatic hyperplasia and prostate adenocarcinoma.
• To identify potential biomarker-driven therapeutic strategies for these conditions.

Main Methods:

• Literature review focusing on epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition in prostate pathology.
• Analysis of phenotypic alterations and transcriptional programming in benign prostatic hyperplasia and prostate adenocarcinoma.
• Discussion of cellular heterogeneity in relation to EMT processes.

Main Results:

• Epithelial-mesenchymal transition (EMT) and mesenchymal-epithelial transition are fundamental processes in prostate gland disorders.
• Phenotypic plasticity driven by EMT programming contributes to benign prostatic hyperplasia and prostate adenocarcinoma development.
• Cellular heterogeneity complicates the understanding of EMT's role in these diseases.

Conclusions:

• Understanding the transcriptional programming of EMT and mesenchymal-epithelial transition is crucial for advancing prostate cancer and benign prostatic hyperplasia research.
• Identifying EMT-related biomarkers can lead to novel therapeutic platforms.
• Targeting these cellular transitions offers a promising avenue for future treatments in urologic oncology and benign prostatic diseases.